No Detail Found!

Coagulopathies of Liver Diseases: a Narrative Review.

Author(s)
Farooq Ahmed Department of Medical Education, Khyber Medical College, Peshawar, Pakistan
Iqbal Haider Department of Medicine, Khyber Medical College, Peshawar, Pakistan
Abstract
Background: Liver is considered to be one of the synthetic organs regarding coagulation factors. Patients with liver disease undergo a rebalanced state, where a procoagulant state is also established along with an anticoagulant state. The risk of thrombosis is as common as the risk of bleeding. Aims and objectives: The following discussion will highlight the importance of rebalanced system and will explain the role of common coagulation tests in patient with advanced liver disease. This discussion will also emphasize the limitation of common coagulation tests and will describe an approach to such patients in clinical settings. Material and Methods: A narrative literature review utilizing PubMed and OVID as databases was carried out in August 2018. Keywords used were: “Advanced liver disease”, “Coagulation disorders”, “Thrombosis and embolism” and “Coagulopathy of liver diseases”. This literature search was confined only to studies performed on human beings and published in English language only.
Publication Details
Page(s) 257-260
DOI DOI not available
Published Journal: Journal of Medical Science, Volume: 26, Issue: 3, Year: 2018

Request the full text from PASTIC

References
KujovichJL, 2015.Coagulopathy in liver disease: a balancing act,Hematology 1 243 -9
IntagliataNM,CaldwellSH, 2017.Changes in hemostasis in liver disease,J of hepat 67 1332 -3
Blasi A., 2015.Coagulopathy in liver disease: Lack of an assessment tool,World J of Gastroenterol 21 10062 -9
2015.In: Seminar on thrombosis,Hemostasis 41 462 -7
MannucciPM,TripodiA, 2012.Liver disease, coagulopathies and transfusion therapy,Blood Transfus 10 12 -6
CaldwellSH, 2014.Management of coagulopathy in liver disease,Gastroenterology & hepatology 10 330 -9
SanerFH,GieselerRK,AkızH,CanbayA,GörlingerK., 2013.Delicate balance of bleeding and thrombosis in end-stage liver disease and liver transplantation,Digestion 10 135 -44
PubMedPMID, ., 24008288 -
KarvellasCJ,CardosoFS,SenzoloM,WellsM,AlghanemMG,HandouF,KwapiszL,KnetemanNM,MarottaPJ,Al-JudaibiB., 2017.Clinical Impact of Portal Vein Thrombosis Prior to Liver Transplantation: A Retrospective Cohort Study,Ann Hepatol 10 236 -56
PubMedPMID, ., 28233745 -
DiNorciaJ,LeeMK,Harlander-LockeMP,XiaV,KaldasFM,ZarrinparA, 2015.Damage control as a strategy to manage post-reperfusion hemodynamic instability and coagulopathy in liver transplant,J Am Med Asso surg 150 1066 -72
NacotiM,CorbellaD,FazziF,RapidoF,BonanomiE, 2005.Coagulopathy and transfusion therapy in pediatric liver transplantation,World J Gastroenterol 10 2005 -23
QiX,DaiJ,JiaJ,RenW,YangM,LiH, 2014.Association between portal vein thrombosis and survival of liver transplant recipients: a systematic review and meta-analysis of observational studies,J Gastrointestin Liver Dis 1121 51 -9
TownsendJC,HeardR,PowersER,ReubenA, 2012.Usefulness of international normalized ratio to predict bleeding complications in patients with end-stageliver disease who undergo cardiac catheterization,Am J Cardiol 05 1062 -5
PannachS,BabatzJ,Beyer-WestendorfJ, 2013.Successful treatment of acute portal vein thrombosis with rivaroxaban,Thromb Haemost 110 626 -7
FloresB,TrivediHD,RobsonSC,BonderA, 2017.Hemostasis, bleeding and thrombosis in liver disease,J Transl Sci 10 1 -7
DougladM,MaureaneH., 2008.The coagulation cascade in cirrhosis,Clinics in Liver Disease 09 1 -9
0

Citations

0

Downloads

62

Views